BROWN, MARYANNE,DUSTIN, MICHAEL,ZANIN-ZHOROV, ALEXANDRA
申请号：
NZ59533110
公开号：
NZ595331A
申请日:
2010.04.28
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
595331 Discloses the use of blood or an isolated blood fraction from a patient which has been treated with an inhibitor of PKC-theta (PKC-?) in the manufacture of a medicament to treat immunological disorders or atherosclerosis in the same patient. Wherein the PKC-theta inhibitor being siRNA or shRNA and where the Treg cells from the patients blood is isolated and re-administered to the patient.
